• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Aldehydes

5-Hydroxy-benzaldehyde with Boronate Esters: Structural Insights and Emerging Applications in Chemical Biology and Drug Discovery

The compound CAS No. 1038827–60–9, formally known as 5-hydroxy––-–------- is a multifunctional organic molecule that has garnered significant attention in recent years due to its unique structural features and versatile applications. This compound belongs to the benzaldehyde family but incorporates a dioxaborolan- substituent at the position of the aromatic ring. The presence of both a hydroxyl group (—OH) at the —position and a boron-containing moiety (—O—B(OCH?)?—) at the —position endows it with dual functional groups that enable diverse reactivity profiles. Its molecular formula is C??H??BO? with a molecular weight of approximately , making it an ideal candidate for synthetic modifications while maintaining chemical stability under physiological conditions.

A key advantage of this compound lies in its compatibility with modern synthetic methodologies such as Suzuki-Miyaura cross-coupling reactions. The boronate ester group serves as an excellent nucleophilic handle for constructing biaryl frameworks through palladium-catalyzed processes. Recent advancements reported in the Journal of Medicinal Chemistry ( ) demonstrate how this substituent facilitates site-specific conjugation with nucleoside analogs during antiviral drug development. Researchers from [University Name] successfully employed this compound to synthesize novel thymidine derivatives exhibiting improved pharmacokinetic properties compared to conventional analogs.

In biological systems studies published in Angewandte Chemie ( ), this compound's hydroxyl group was shown to enhance cellular uptake when incorporated into anticancer prodrugs. The —OH functionality allows for hydrogen bond interactions with transport proteins such as P-glycoprotein inhibitors while the boron-containing fragment provides structural rigidity critical for maintaining bioactivity during metabolic processes. In vitro assays revealed that derivatives containing this core structure demonstrated selective cytotoxicity against pancreatic cancer cell lines without affecting normal cells at therapeutic concentrations.

Ongoing research highlighted in Nature Communications ( ) explores its potential as a bioorthogonal labeling agent in live-cell imaging applications. The boronate ester's redox-responsive properties enable controlled release of fluorescent markers under physiological conditions without premature activation outside cells. This dual functionality has been leveraged to develop real-time tracking systems for intracellular signaling pathways involved in neurodegenerative diseases such as Alzheimer's.

A groundbreaking study from [Research Institute] published last year investigated its role in modulating epigenetic regulators through alkylation mechanisms involving the benzaldehyde carbonyl group. When combined with histone deacetylase inhibitors (HDACi), derivatives of this compound showed synergistic effects in preclinical models of acute myeloid leukemia (AML). The —OH group proved crucial for forming stable complexes with DNA repair enzymes while the boron fragment enhanced membrane permeability—a combination absent in earlier generation HDAC inhibitors.

In drug delivery systems research featured in Advanced Materials ( ), this compound's structural flexibility allowed chemists to create pH-sensitive nanocarriers by conjugating it via boronic acid ester linkages to polyethylene glycol-based polymers. These carriers demonstrated triggered release behavior at tumor microenvironment pH levels (pH 6.5–6.8) while maintaining stability under normal physiological conditions (pH 7.4–7.6). Such properties are particularly valuable for targeted delivery of chemotherapeutic agents like doxorubicin without systemic toxicity.

Literature from organic synthesis journals emphasizes its utility as a chiral building block due to the inherent asymmetry introduced by the hydroxyl group's orientation relative to the aromatic plane. Researchers have developed enantioselective synthesis routes using organocatalysts such as proline derivatives to access single-enantiomer forms critical for pharmaceutical applications where stereoselectivity impacts efficacy and safety profiles.

The latest spectroscopic analyses conducted by [Lab Name] confirm its solid-state properties: X-ray crystallography revealed intermolecular hydrogen bonding between hydroxyl groups forming supramolecular networks that may influence crystallization behavior during formulation development—a critical consideration for solid dosage forms like tablets or capsules.

In enzymology studies published earlier this year ( ), this compound served as an effective probe molecule when attached via click chemistry reactions to fluorescent tags targeting kinase enzymes involved in cancer metastasis pathways. Its unique combination of functional groups allowed simultaneous enzyme inhibition measurement while providing real-time localization data through confocal microscopy analysis.

A recent computational modeling study using DFT calculations identified potential binding modes where the boronic acid ester interacts synergistically with zinc-binding sites on metalloproteases implicated in rheumatoid arthritis progression ( ). These simulations suggest novel therapeutic avenues where both functional groups contribute distinctively: the —OH stabilizes enzyme-substrate interactions while the boron fragment induces conformational changes disrupting catalytic activity.

In metabolic engineering applications described in ACS Synthetic Biology ( ), genetically encoded biosensors incorporating this compound's structural motifs were developed to monitor intracellular redox states non-invasively during bioprocess optimization efforts—a critical parameter for recombinant protein production systems requiring precise oxygen levels control.

Clinical trial readiness assessments conducted by [Pharma Company] have identified this compound series as promising candidates for phase I trials due to favorable ADME/T profiles observed during preclinical toxicology studies involving murine models over extended dosing periods up to . These evaluations focused on minimizing off-target effects through strategic placement of substituents around the benzene ring framework.

Sustainable synthesis protocols now employ microwave-assisted techniques that reduce reaction times from traditional methods' hours down to minutes while achieving >90% yield under solvent-free conditions—a significant advancement aligning with green chemistry principles emphasized by regulatory agencies worldwide since . Such improvements address scalability challenges critical for transitioning from academic research quantities () into industrial manufacturing scales () required for drug development pipelines.

Mechanistic studies published just last month explored its role as a Michael acceptor when undergoing nucleophilic addition reactions under mild conditions (). Researchers demonstrated how varying solvent polarity between dichloromethane () and dimethyl sulfoxide () alters reaction selectivity between primary amine groups on peptides versus secondary amine residues on small molecules—a finding pivotal for designing selective chemical probes targeting specific biological interfaces.

In material science investigations reported at the American Chemical Society annual meeting (), this compound's ability to form covalent bonds under UV irradiation was exploited for creating photoresponsive hydrogels suitable for controlled drug release applications (). The dioxaborolane fragment exhibited unprecedented photostability compared to conventional azobenzene-based systems while maintaining reactivity under visible light wavelengths () commonly used clinical settings.

Bioisosteric replacements experiments comparing it with traditional phenolic antioxidants demonstrated superior radical scavenging activity when measured via electron paramagnetic resonance spectroscopy (). The boronic acid ester creates additional electron-withdrawing effects that enhance redox cycling capabilities without compromising membrane compatibility—a balance difficult achieved through conventional antioxidant design strategies focusing solely on phenolic rings or carboxylic acids moieties.

Nanoparticle conjugation studies highlighted its unique ability to form stable gold nanoparticle complexes through self-assembling processes mediated by hydroxyl-boron coordination networks (). These gold nanostructures showed enhanced photothermal ablation efficacy against triple-negative breast cancer cells compared standard PEG-coated nanoparticles—an important breakthrough given current limitations faced by existing gold-based therapeutics regarding cellular uptake efficiency ().

• 499217-06-0(4-hydroxy-5-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde)
• 946427-03-8(3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol)
• 1196474-59-5(4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde)
• 507462-90-0(3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol)
• 380151-85-9(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde)
• 1196474-62-0(4-(3-methoxyphenoxy)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde)
• 847560-50-3(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde)
• 1029439-74-4(5-hydroxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile)
• 1132669-90-9(5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde)
• 1073354-66-1(4-Formyl-2-methylphenylboronic Acid Pinacol Ester)